Earnings reports are critical events for companies and their investors. When a company like Ginko Bioworks Holdings reports sales figures that are below market expectations, it often leads to a negative reaction in the stock market. Investors and analysts closely watch these reports to adjust their expectations for the company's financial health and future performance. In this case, the worse-than-expected sales results for Q1 are likely to shake investors' confidence in DNA, at least in the short term, leading to a decrease in stock price.